WB and immunofluorescence analysis further corroborated the decrease in α‐SMA and Col1A1 expression in the skin of BLM‐SSc mice treated with anti‐IL‐17RA mAb (Figure 7F,G). Here, ACTA1 is linked to systemic sclerosis.